Day 1

DAY 1 – MONDAY 26 FEBRUARY 2018

Introduction – Heinz Zwierzina (CDDF Managing Director, AT)

Keynote Lecture: Clinical Trial Design in 2050; or: The Disappearance of Clinical Trials? – Jaap Verweij (Erasmus MC, NL) – please contact CDDF to access the slides

PLENARY SESSION 1: CLINICAL TRIAL DESIGN IN AN ERA OF HORIZONTAL DRUG DEVELOPMENT

• Statistician’s Perspective – Lindsay Renfro (Mayo Clinic, USA)
• Industry Perspective – Davy Chiodin (Acerta/AstraZeneca Group, USA)

PLENARY SESSION 2 (PART I): RARE CANCERS

• The Joint Action on Rare Cancers (JARC): European initiatives – Paolo Casali (Fondazione IRCCS Istituto Nazionale Tumori/University of Milan, IT)
• EU Reference Networks – Jean-Yves Blay (Léon Bérard Centre, FR)